RNS Number: 9554X

Young & Co.'s Brewery, P.L.C.

25 March 2026

THIS ANNOUNCEMENT IS MADE FOR INFORMATION PURPOSES ONLY AND DOES NOT CONSTITUTE OR FORM PART OF, AND SHOULD NOT BE CONSTRUED AS, AN OFFER TO SELL OR ISSUE OR SOLICITATION TO BUY, SUBSCRIBE FOR OR OTHERWISE ACQUIRE ANY SHARES IN YOUNG & CO.'S BREWERY, P.L.C. IN ANY JURISDICTION.

YOUNG & CO.'S BREWERY, P.L.C. ("Young's" or the "Company")

UPDATE ON MOVE TO THE MAIN MARKET

Young's, the premium operator of pubs and bedrooms in London and the South of England, today provides an update on the proposed admission of: (i) its entire issued A ordinary share capital (the "A Ordinary Shares") to the equity shares (commercial companies) category (the "ESCC") of the Official List of the FCA (the "Official List"); (ii) its entire issued non‑voting ordinary share capital (the "Non-Voting Ordinary Shares", together with the A Ordinary Shares, the "Ordinary Shares") to the non‑equity shares and non‑voting equity shares category of the Official List; and (iii) the Ordinary Shares to trading on the main market for listed securities of the London Stock Exchange (the "Main Market") (together "Admission").

Further to its announcement on 22 January 2026, the Company now expects that: (i) Admission will take place at 8.00 a.m. on 28 April 2026; and (ii) the Ordinary Shares will be cancelled from trading on AIM at 8.00 a.m. on 28 April 2026. The last day of trading in the Ordinary Shares on AIM is therefore expected to be 27 April 2026. Admission will be effected through an introduction of the Company's existing Ordinary Shares and the Company is not offering any new Ordinary Shares nor any other securities in connection with the proposed Admission. Accordingly, the Company hereby gives notice of the intended cancellation of trading of its Ordinary Shares on AIM in accordance with Rule 41 of the AIM Rules for Companies. Such cancellation is not subject to shareholder approval.

Admission remains subject to a number of conditions, including: (i) the approval by the FCA of a prospectus and the A Ordinary Shares being admitted by the FCA to the ESCC category of the Official List and the Non‑Voting Ordinary Shares being admitted by the FCA to the non‑equity shares and non‑voting equity shares category of the Official List; and (ii) admission by the London Stock Exchange of the Ordinary Shares to trading on the Main Market.

Shareholders should note that the Ordinary Shares will no longer be traded on AIM with effect from Admission and should take their own financial and taxation advice regarding the consequences of Admission.

Peel Hunt and Stifel are acting as Joint Sponsors exclusively to the Company and no one else in connection with the proposed Admission.

Further announcements will be made in due course.

For further information, please contact:

Important information

Neither this announcement, nor any copy of it, may be taken or transmitted, published or distributed, directly or indirectly, in or into or from the United States, Australia, Canada, Japan or the Republic of South Africa or any other jurisdiction where to do so would constitute a violation of the relevant securities laws of such jurisdiction. This announcement is for information purposes only and does not constitute an offer to sell or issue, or the solicitation of an offer to buy, acquire or subscribe for any Ordinary Shares in any jurisdiction. Any failure to comply with these restrictions may constitute a violation of the securities laws of such jurisdictions.

The Ordinary Shares have not been, and will not be, registered under the US Securities Act of 1933, as amended (the "US Securities Act"), or under any securities laws of any state or other jurisdiction of the United States and may not be offered, sold, resold, transferred or delivered, directly or indirectly, in or into or from the United States except pursuant to an applicable exemption from, or in a transaction not subject to, the registration requirements of the US Securities Act and in compliance with the securities laws of any state or other jurisdiction of the United States. There will be no offering of Ordinary Shares in the United States or in any other jurisdiction in connection with Admission.

This announcement may include statements, beliefs or opinions that are, or may be deemed to be, "forward-looking statements". These forward-looking statements may be identified by the use of forward-looking terminology, including the terms "believes", "estimates", "plans", "projects", "anticipates", "targets", "aims", "continues", "expects", "intends", "hopes", "may", "will", "would", "could" or "should" or, in each case, their negative or other variations or comparable terminology, or by discussions of strategy, plans, objectives, goals, future events or intentions. No representation or warranty is made that any of these statements or forecasts will come to pass or that any forecast results will be achieved. Forward-looking statements may and often do differ materially from actual results. Any forward-looking statements contained in the announcement speak only as of their respective dates, reflect the Company's current view with respect to future events and are subject to risks relating to future events and other risks, uncertainties and assumptions relating to the Company's business, results of operations, financial position, liquidity, prospects, growth and strategies.

Except as required by any applicable law or regulation, Young's expressly disclaims any obligation or undertaking to release publicly any updates or revisions to any forward-looking statements contained in this announcement or any other forward-looking statements it may make whether as a result of new information, future developments or otherwise.

Peel Hunt LLP ("Peel Hunt"), which is authorised and regulated in the United Kingdom by the FCA, is acting exclusively for the Company and no one else in connection with Admission, the contents of this announcement or any other matters described in this announcement and will not regard any other person as its client in relation to Admission, the content of this announcement or any other matters described in this announcement and will not be responsible to anyone other than the Company for providing the protections afforded to its clients or for providing advice in relation to Admission, the content of this announcement or any other matters referred to in this announcement.

Stifel Nicolaus Europe Limited ("Stifel", together with Peel Hunt, the "Joint Sponsors"), which is authorised and regulated in the United Kingdom by the FCA, is acting exclusively for the Company and no one else in connection with Admission, the contents of this announcement or any other matters described in this announcement and will not regard any other person as its client in relation to Admission, the content of this announcement or any other matters described in this announcement and will not be responsible to anyone other than the Company for providing the protections afforded to its clients or for providing advice in relation to Admission, the content of this announcement or any other matters referred to in this announcement.

Apart from the responsibilities and liabilities, if any, which may be imposed on the Joint Sponsors by FSMA or the regulatory regime established thereunder or under the regulatory regime of any other applicable jurisdiction where exclusion of liability under the relevant regulatory regime would be illegal, void or unenforceable, neither of the Joint Sponsors nor any of their affiliates accept any responsibility whatsoever (whether direct or indirect, whether in contract, in tort, under statute or otherwise) to any person in connection with this announcement, any statement contained herein or otherwise, nor makes any representation or warranty, express or implied, in relation to, the contents of this announcement, including its accuracy, completeness or verification or for any other statement made or purported to be made by the Company, or the Joint Sponsors, or on their behalf, in connection with the Company or its subsidiaries, the Ordinary Shares or Admission. The Joint Sponsors and each of their affiliates accordingly disclaim, to the fullest extent permitted by applicable law, all and any liability whether arising in tort, contract or otherwise (save as referred to above) which they might otherwise be found to have in respect of this announcement or any such statement. No representation or warranty, express or implied, is made by either of the Joint Sponsors or any of their affiliates as to the accuracy, completeness, verification or sufficiency of the information set out in this announcement, and nothing in this announcement will be relied upon as a promise or representation in this respect, whether or not to the past or future.